The Effect of Accompanying Temporomandibular Joint Dysfunction in Patients With Chronic Migraine
1 other identifier
interventional
62
1 country
1
Brief Summary
The aim of this clinical study to evaluate the effect of temporomandibular joint dysfunction accompanying patients with chronic migraine on pain, quality of life, sleep and functionality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2022
CompletedFirst Submitted
Initial submission to the registry
May 14, 2022
CompletedFirst Posted
Study publicly available on registry
May 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2022
CompletedSeptember 28, 2023
September 1, 2023
6 months
May 14, 2022
September 26, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Allodynia
The patients will be evaluated for allodynia with the Allodynia Symptom Checklist. The Allodynia Symptom Checklist include 12 questions about the frequency of various allodynia symptoms in association with headache attacks. Instead of using a dichotomous option (yes or no), the response categories are "never," "rarely," "less than half the time," and "half the time or more." In addition, subjects can also indicate that an item "does not apply to me." That option is used by someone who never shaved their face or someone who never wore a ponytail.
7 days
Health-Related Quality
The patients will be evaluated for the quality of life with The Short Form-36. This form is composed of 36 items and eight subscales to evaluate quality of life (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health). The scores of the subscales range between 0 and 100, and higher scores indicate higher quality of life.
7 days
Headache-related disability
The patients will be evaluated for headache-related disability with The Migraine Disability Assessment Test. Migraine Disability Assessment scores (numerical scores represent number of days patients missed or lost productivity at work or school, as well as missed days from family/social/leisure activities, and range from little or no disability (0-5) to severe disability (\>20).
3 months
The impact of headache on quality of life
The patients will be evaluated for the impact of headache on quality of life with 6-item short-form Headache Impact Test. This test is a patient-reported outcome measure used to measure the impact and effect of headache on the ability to function normally in daily life. It consists of 6 questions, total scores may range from 36 to 78 and higher scores reflecting greater impact.
3 months
Sleep quality
The patients will be evaluated for sleep quality with the Pittsburgh Sleep Quality Index. It contains 19 self-reported items and 5 items to be completed by a bed partner or roommate, if possible. Scores range from 0 to 3, and are summed to obtain a global score, which ranges from 0 to 21. Higher scores indicate greater sleep disturbance.
7 days
Temporomandibular dysfunction
The patients will be evaluated for temporomandibular dysfunction with Helkimo Clinical Dysfunction Index. This index include the following signs: impaired range of movement of the mandible, impaired function of the joint, pain with movement of the mandible, muscle pain, and joint pain. Patients are given a score of 0 points for absence of symptoms, 1 point for mild pain or dysfunction, and 5 points for severe pain or dysfunction.
7 days
Secondary Outcomes (1)
Descriptive information
3 days
Study Arms (2)
Chronic migraine
OTHERPatients diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3).
Temporomandibular dysfunction
OTHERPatients diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3), and patients with temporomandibular dysfunction.
Interventions
All patients will be evaluated for allodynia, quality of life, headache-related disability, and sleep quality.
Patients with jaw complaints will be evaluated for temporomandibular joint dysfunction.
Eligibility Criteria
You may qualify if:
- For patients with chronic migraine:
- Being diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3)
- Being literate
- For patients with temporomandibular dysfunction :
- Diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3)
- Being literate
- Pain in the temporomandibular joint region and chewing muscles for at least 3 months, limitation in mouth opening, noise from the joint when opening the mouth, and / or having complaints and findings such as non-harmonic jaw movements
- Getting a score of ≥1 according to the Helkimo Clinical Craniomandibular Dysfunction Index
You may not qualify if:
- For patients with chronic migraine:
- Complaint of chronic pain in another part of their body other than the head and face region
- Having another pathology that can explain their pain in the head and face region other than chronic migraine (such as sinusitis, tension-type headache, trigeminal neuralgia, drug overuse headache)
- Psychiatric disease or using psychiatric drugs
- History of serious head trauma or neurosurgical intervention
- Those with a history of infectious, chronic inflammatory disease, malignancy
- Pregnant and breastfeeding women
- History of additional neurological disease other than migraine
- Uncooperative
- Having congestive heart failure, chronic kidney failure, chronic liver disease, lung disease, uncontrolled diabetes, peripheral vascular disease
- Presence of trauma or operation in the temporomandibular joint
- History of facial paralysis
- Actively receiving treatment related to the temporomandibular joint
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University- Cerrahpasa
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Uğur Uygunoğlu, MD
Istanbul University - Cerrahpasa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 14, 2022
First Posted
May 19, 2022
Study Start
May 10, 2022
Primary Completion
November 20, 2022
Study Completion
November 20, 2022
Last Updated
September 28, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share